These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 11819030

  • 1. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ, Trivedi BL, de Paulis T, Schmidt DE, Hewlett WA.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
    [Abstract] [Full Text] [Related]

  • 2. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M, Kiel S, Bönisch H, Kostanian A, Göthert M.
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [Abstract] [Full Text] [Related]

  • 3. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A, Anzini M, Vomero S, Canullo L, Mennuni L, Makovec F, Doucet E, Hamon M, Menziani MC, De Benedetti PG, Bruni G, Romeo MR, Giorgi G, Donati A.
    J Med Chem; 1999 May 06; 42(9):1556-75. PubMed ID: 10229626
    [Abstract] [Full Text] [Related]

  • 4. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
    Hewlett WA, Trivedi BL, Zhang ZJ, de Paulis T, Schmidt DE, Lovinger DM, Ansari MS, Ebert MH.
    J Pharmacol Exp Ther; 1999 Jan 06; 288(1):221-31. PubMed ID: 9862774
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S.
    J Med Chem; 2003 Feb 27; 46(5):702-15. PubMed ID: 12593651
    [Abstract] [Full Text] [Related]

  • 6. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I, Alonso-Cires L, López-Tudanca PL, Mosquera R, Labeaga L, Innerárity A, Orjales A.
    J Med Chem; 1999 Jul 29; 42(15):2870-80. PubMed ID: 10425096
    [Abstract] [Full Text] [Related]

  • 7. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D, Neijt HC.
    Mol Pharmacol; 1988 Mar 29; 33(3):303-9. PubMed ID: 3352595
    [Abstract] [Full Text] [Related]

  • 8. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    Labrecque J, Fargin A, Bouvier M, Chidiac P, Dennis M.
    Mol Pharmacol; 1995 Jul 29; 48(1):150-9. PubMed ID: 7623769
    [Abstract] [Full Text] [Related]

  • 9. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Doucet E, Hamon M, Bruni G, Romeo MR, Menziani MC, De Benedetti PG, Langer T.
    J Med Chem; 1998 Feb 26; 41(5):728-41. PubMed ID: 9513601
    [Abstract] [Full Text] [Related]

  • 10. Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue.
    Hirst WD, Minton JA, Bromidge SM, Moss SF, Latter AJ, Riley G, Routledge C, Middlemiss DN, Price GW.
    Br J Pharmacol; 2000 Aug 26; 130(7):1597-605. PubMed ID: 10928963
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ, Parrish JC, Jensen NH, Kurrasch-Orbaugh DM, Marona-Lewicka D, Nichols DE.
    J Med Chem; 2003 Jul 31; 46(16):3526-35. PubMed ID: 12877591
    [Abstract] [Full Text] [Related]

  • 12. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V.
    J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit.
    Chidlow G, De Santis LM, Sharif NA, Osborne NN.
    Invest Ophthalmol Vis Sci; 1995 Oct 16; 36(11):2238-45. PubMed ID: 7558717
    [Abstract] [Full Text] [Related]

  • 14. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.
    Carrick T, Kowal D, Nawoschik S, Zhang G, Chan K, Dunlop J.
    Anal Biochem; 2008 Oct 01; 381(1):27-32. PubMed ID: 18601889
    [Abstract] [Full Text] [Related]

  • 15. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
    Bonhaus DW, Loury DN, Jakeman LB, Hsu SA, To ZP, Leung E, Zeitung KD, Eglen RM, Wong EH.
    J Pharmacol Exp Ther; 1994 Oct 01; 271(1):484-93. PubMed ID: 7965749
    [Abstract] [Full Text] [Related]

  • 16. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD.
    Mol Pharmacol; 2003 Dec 01; 64(6):1295-308. PubMed ID: 14645659
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA, Wong EH, Loury DN, Stefanich E, Michel AD, Eglen RM, Whiting RL.
    Br J Pharmacol; 1991 Apr 01; 102(4):919-25. PubMed ID: 1830236
    [Abstract] [Full Text] [Related]

  • 18. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S, Sallés J.
    Neuropharmacology; 2009 Feb 01; 56(2):455-62. PubMed ID: 18951909
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
    Wainscott DB, Cohen ML, Schenck KW, Audia JE, Nissen JS, Baez M, Kursar JD, Lucaites VL, Nelson DL.
    Mol Pharmacol; 1993 Mar 01; 43(3):419-26. PubMed ID: 8450835
    [Abstract] [Full Text] [Related]

  • 20. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
    Choi SK, Green D, Ho A, Klein U, Marquess D, Taylor R, Turner SD.
    J Med Chem; 2008 Jun 26; 51(12):3609-16. PubMed ID: 18507369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.